Skip to content
Home/Companies/MedTech/Hedera Dx
Hedera Dx

Hedera Dx

MedTech·Switzerland·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Hedera Dx?

Hedera Dx is a Swiss MedTech company, currently owned by Vsquared Ventures since 2025.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Vsquared Ventures
Investor
Vsquared Ventures
Vsquared Ventures II · 2024 · VC

Key facts

HQSwitzerland
SectorMedTech
StatusActive
Websitewww.hederadx.com

More from Vsquared Ventures II

Other portfolio companies in the same fund.

Arlequin AI
Active
SoftwareFrance· 2025
Atrandi Biosciences
Atrandi Biosciences
Active
BiotechLithuania· 2025
Belfort
Belfort
Active
Deep TechBelgium· 2025
Pulsetrain
Active
MobilityGermany· 2025
Cylib
Cylib
Active
ClimateTechGermany· 2024
Kano Therapeutics
Kano Therapeutics
Active
BiotechUS· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Hedera Dx?

Hedera Dx is currently owned by Vsquared Ventures, through Vsquared Ventures II, since 2025.

When did Vsquared Ventures acquire Hedera Dx?

Vsquared Ventures acquired Hedera Dx in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue